Generic placeholder image

Cardiovascular & Hematological Agents in Medicinal Chemistry

Author(s): Elahe Razmara Lak, Sedigheh Sharifzadeh, Mani Ramzi, Maral Mokhtari, Reza Asadpouri, Elham Abedi and Gholamhossein Tamaddon*

DOI: 10.2174/1871525721666230614110621

DownloadDownload PDF Flyer Cite As
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Blastic Crisis in a Patient with Unusual Primary Myelofibrosis Characteristics; A Case Report

Page: [240 - 245] Pages: 6

  • * (Excluding Mailing and Handling)

Abstract

Introduction: Myeloproliferative neoplasms (MPNs) are divided into BCR-ABL positive Chronic myeloid leukemia (CML) and BCR-ABL negative MPNs including Polycythemia vera (PV), Essential Thrombocythemia (ET) and Primary myelofibrosis (PMF). Evaluation of the Philadelphia chromosome in MPNs is a diagnostic requirement for classic CML.

Case Report: In 2020, a 37-year-old woman with negative cytogenetic testing for Janus kinase2 (JAK2), Calreticulin (CALR), myeloproliferative leukemia virus oncogene (MPL), and positive for BCR-ABL1 mutation with reticular fibrosis in bone marrow was diagnosed as CML. Some years ago, the patient had been diagnosed with PMF with evidence of histiocytic necrotizing lymphadenitis or Kikuchi-Fujimoto disease (KFD). The BCR-ABL fusion gene was initially evaluated which was negative. Then, Cutaneous squamous cell carcinoma (cSCC) was confirmed by Dermatopathologist with palpable splenomegaly and high white blood cell (WBC) count with basophilia. Finally, BCR-ABL was detected positive by the fluorescence in situ hybridization (FISH) and quantitative real-time polymerase chain reaction (qRT-PCR). In fact, the co-occurrence of PMF with CML was identified.

Conclusion: This case study highlighted the importance of some cytogenetic methods in the detection and classification of MPNs. It is recommended that physicians pay more attention to it and be aware of the planning treatment.

Graphical Abstract

[1]
Koshy, J.; Alperin, J.; Jana, B.; Markowitz, A.; Qian, Y-W. A case of Philadelphia chromosome positive myeloproliferative neoplasm in a pregnant woman with unusual primary myelofibrosis features. Case reports in hematology, 2013, 2013, 702831.
[http://dx.doi.org/10.1155/2013/702831]
[2]
Bhatt, V.R. Leukemic transformation in essential thrombocythemia. Future Oncol., 2014, 10(16), 2593-2602.
[http://dx.doi.org/10.2217/fon.14.239] [PMID: 25531047]
[3]
Cotta, C.V.; Bueso-Ramos, C.E. New insights into the pathobiology and treatment of chronic myelogenous leukemia. Ann. Diagn. Pathol., 2007, 11(1), 68-78.
[http://dx.doi.org/10.1016/j.anndiagpath.2006.12.002] [PMID: 17240312]
[4]
Curtin, N.J.; Campbell, P.J.; Green, A.R. The Philadelphia translocation and pre-existing myeloproliferative disorders. Br. J. Haematol., 2005, 128(5), 734-736.
[http://dx.doi.org/10.1111/j.1365-2141.2005.05396.x] [PMID: 15725099]
[5]
Laibe, S.; Tadrist, Z.; Arnoulet, C.; Sainty, D.; Mozziconacci, M.J. A myeloproliferative disorder may hide another one. Leuk. Res., 2009, 33(8), 1133-1136.
[http://dx.doi.org/10.1016/j.leukres.2009.01.034] [PMID: 19250672]
[6]
Mizutani, S.; Kuroda, J.; Shimizu, D.; Horiike, S.; Taniwaki, M. Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia. Int. J. Hematol., 2010, 91(3), 516-521.
[http://dx.doi.org/10.1007/s12185-010-0502-3] [PMID: 20146031]
[7]
Pandey, A.; Yadav, A.K.; Barthwal, M.; Tiwari, D.; Gupta, R. CML presenting synchronously with squamous cell carcinoma of cervix: A case report. Indian J Pathol Oncol., 2019, 6(1), 146-147.
[http://dx.doi.org/10.18231/2394-6792.2019.0026]
[8]
Jones, A.V.; Kreil, S.; Zoi, K.; Waghorn, K.; Curtis, C.; Zhang, L.; Score, J.; Seear, R.; Chase, A.J.; Grand, F.H.; White, H.; Zoi, C.; Loukopoulos, D.; Terpos, E.; Vervessou, E.C.; Schultheis, B.; Emig, M.; Ernst, T.; Lengfelder, E.; Hehlmann, R.; Hochhaus, A.; Oscier, D.; Silver, R.T.; Reiter, A.; Cross, N.C. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood, 2005, 106(6), 2162-2168.
[http://dx.doi.org/10.1182/blood-2005-03-1320] [PMID: 15920007]
[9]
Baskaynak, G.; Kreuzer, K.A.; Schwarz, M.; Zuber, J.; Audring, H.; Riess, H.; Dörken, B.; Le Coutre, P. Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment. Eur. J. Haematol., 2003, 70(4), 231-234.
[http://dx.doi.org/10.1034/j.1600-0609.2003.00044.x] [PMID: 12656746]
[10]
Rogers, H.W.; Weinstock, M.A.; Feldman, S.R.; Coldiron, B.M. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol., 2015, 151(10), 1081-1086.
[http://dx.doi.org/10.1001/jamadermatol.2015.1187] [PMID: 25928283]
[11]
Mittal, D.; Gubin, M.M.; Schreiber, R.D.; Smyth, M.J. New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape. Curr. Opin. Immunol., 2014, 27, 16-25.
[http://dx.doi.org/10.1016/j.coi.2014.01.004] [PMID: 24531241]
[12]
Khieu, M.; Beauvais, A.; Matz, R.; Bersabe, A.; Brown, P.; Brown, A.; Fillman, E.; Hall, J. Aleukemic myeloid leukemia cutis with a kikuchi disease–like inflammatory pattern in myelodysplastic syndrome. South. Med. J., 2017, 110(4), 308-313.
[http://dx.doi.org/10.14423/SMJ.0000000000000634] [PMID: 28376531]
[13]
Shahid, S.; Alam, S.H.; Hadley, I. An unusual presentation of Kikuchi-Fujimoto disease with recurrent subdural effusion. Cureus, 2018, 10(3), e2302.
[http://dx.doi.org/10.7759/cureus.2302] [PMID: 29755898]
[14]
Kido, H.; Kano, O.; Hamai, A.; Masuda, H.; Fuchinoue, Y.; Nemoto, M.; Arai, C.; Takeda, T.; Yamabe, F.; Tai, T.; Kasahara, M.; Suzuki, K.; Shiraga, N.; Sadamoto, S.; Wakayama, M.; Takahashi, Y.; Iwasaki, Y.; Shibuya, K.; Urita, Y. Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis) with atypical encephalitis and painful testitis: A case report. BMC Neurol., 2017, 17(1), 22.
[http://dx.doi.org/10.1186/s12883-017-0807-4] [PMID: 28143446]
[15]
Srikantharajah, M; Mahendra, P; Vydianath, B; Lowe, GC Kikuchi-Fujimoto disease: A rare but important differential diagnosis for lymphadenopathy. Case Reports, 2014, 2014, bcr2014205470.
[http://dx.doi.org/10.1136/bcr-2014-205470]